Monthly administration of rituximab is useful for patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma
Crossref DOI link: https://doi.org/10.1038/bcj.2014.65
Published Online: 2014-09-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mino, T
Mihara, K
Yoshida, T
Takihara, Y
Ichinohe, T
Text and Data Mining valid from 2014-09-12
Version of Record valid from 2014-09-12
Article History
First Online: 12 September 2014
Competing interests
: The authors declare no conflict of interest.